Last checked at 21 Dec 2021 07:29
AstraZeneca neuromuscular treatment gets US priority review
(Sharecast News) - AstraZeneca on Tuesday said its neuromuscular treatment had been accepted for priority review in the US.
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News
AZN Share
Chat
AZN Share
Trades
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
11,268.00
Bid:
11,222.00
Ask:
11,226.00
Change:
0.00 (0.00%)
Spread:
4.00 (0.036%)
Open:
0.00
High:
0.00
Low:
0.00
Prev. Close:
11,268.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.20 Dec 2021 17:13
UPDATE 1-UK's Johnson says: we're looking all kinds of things to tackle Omicron
(Recasts headline and lead)LONDON, Dec 20 (Reuters) - British Prime Minister Boris Johnson said on Monday that he was looking at all kinds of things to keep the Omicron variant under control as the situation was extremely difficult, cautioning tha...
Read more20 Dec 2021 17:00
UK's Johnson warns: we can't exclude further action on COVID
LONDON, Dec 20 (Reuters) - British Prime Minister Boris Johnson said on Monday that he would take further action to tackle the spread of the Omicron variant of the coronavirus if necessary.Johnson said the situation was "extremely difficult" and ...
Read more20 Dec 2021 08:47
AstraZeneca's lupus drug Saphnelo recommended for EU approval
AstraZeneca's lupus drug Saphnelo recommended for EU approval
Read more20 Dec 2021 07:53
LONDON MARKET PRE-OPEN: Former Tesco chief to chair Glaxo consumer
LONDON MARKET PRE-OPEN: Former Tesco chief to chair Glaxo consumer
Read more20 Dec 2021 07:42
AstraZeneca-Amgen asthma drug gets US approval
(Sharecast News) - The AstraZeneca-Amgen asthma drug Tezspire has been approved by the US Food and Drug Administration to treat of adult and paediatric patients aged 12 years and older, the two companies said on Monday.
Read more20 Dec 2021 07:21
AstraZeneca lupus treatment wins EU marketing approval
(Sharecast News) - AstraZeneca's lupus treatment has received marketing authorisation by the European Union, the company said on Monday.
Read more17 Dec 2021 17:26
UPDATE 1-Omicron more likely to reinfect than Delta, no milder -study
* Omicron five times likelier to cause reinfections* No sign milder than Delta, but some say too early to know* Two-dose vaccines offer little or no Omicron protection (Adds detail, reaction, quotes, context)By Clara-Laeila LaudetteDec 17 (Reuters) ...
Read more16 Dec 2021 16:42
UPDATE 8-Oil rises around 2% on strong U.S. demand, upbeat Fed outlook
* Upbeat U.S. Federal Reserve boosts risk appetite* U.S. crude inventories drop more than expected, demand surges* Saudi Arabia's October crude oil exports hit 18-month high* Britain, South Africa post biggest rise in daily COVID-19 cases (Updates...
Read more16 Dec 2021 16:42
UPDATE 7-Oil rises about 2% on strong U.S. demand, upbeat Fed outlook
* Upbeat U.S. Federal Reserve boosts risk appetite* U.S. crude inventories drop more than expected, demand surges* Britain, S. Africa post biggest rise in daily COVID-19 cases (Updates prices, market activity)By Stephanie KellyNEW YORK, Dec 16 (Re...
Read more16 Dec 2021 15:00
TOP NEWS: Astra's Covid antibody retains activity against Omicron
TOP NEWS: Astra's Covid antibody retains activity against Omicron
Read more16 Dec 2021 12:57
UPDATE 2-AstraZeneca therapy works against Omicron; results mixed for Regeneron
* Evusheld retains neutralising activity against Omicron* REGEN-COV showed diminished potency; active against Delta* More data on AstraZeneca's Evusheld expected 'very soon' (Writes through with details on AstraZeneca's drug, background)By Mrinalika...
Read more16 Dec 2021 09:39
LONDON BROKER RATINGS: Deutsche cuts Abrdn; UBS raises Dunelm
LONDON BROKER RATINGS: Deutsche cuts Abrdn; UBS raises Dunelm
Read more16 Dec 2021 08:32
UPDATE 3-European shares rally as ECB promises support
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* ECB dials back stimulus a notch* Airbus wins aircraft deals from Qantas and Air France-KLM* UK bank shares leap as BoE hikes rates* Euro zo...
Read more16 Dec 2021 06:01
INSIGHT-Refugees lack COVID shots because drugmakers fear lawsuits - documents
By Francesco Guarascio and Panu Wongcha-umBRUSSELS/BANGKOK, Dec 16 (Reuters) - Tens of millions of migrants may be denied COVID-19 vaccines from a global programme because some major manufacturers are worried about legal risks from harmful side ef...
Read more